[wc_row][wc_column size=”one-fourth” position=”first”] [/wc_column][/wc_row] [wc_row][wc_column size=”one-fourth” position=”first”]   [/wc_column][wc_column size=”three-fourth” position=”last”]

Kristi Jaska
Vice President of Engineering, ViaSat

Kristi started her career at Linkabit, the fountainhead of San Diego’s telecom industry, where she worked with the three founders of ViaSat.  She then joined ViaSat as the 6^th employee just about a year after the company was founded.  During her time at ViaSat she has worked to grow the company in many areas including hardware, software, and system design; project and business management; and strategy and marketing.  She co-founded ViaSat’s innovation center and holds numerous patents in digital communications. 

Kristi has B.S. and M.Eng degrees in Electrical Engineering from Cornell University.

 

[wc_row][wc_column size=”one-fourth” position=”first”] [/wc_column][/wc_row] [wc_row][wc_column size=”one-fourth” position=”first”] [/wc_column][wc_column size=”three-fourth” position=”last”]

Tristan Barnum
Co-Founder and CMO, Tellient

Tristan is co-founder and CMO of Tellient, an analytics platform built for the Internet of Things. She has served as CMO at VoIP service provider Telcentris. In 2003, Tristan co-founded Switchvox, which was acquired by Digium, the Asterisk Company, in 2007 to serve the rapidly growing SMB market for VoIP phone systems. Prior to Switchvox, Tristan pioneered the online delivery of digital media at MP3.com, which Vivendi Universal acquired. Her work included the design of new web services, handheld mp3 players, tablets and interactive TV. While at Vivendi, she was awarded a patent for a system that provides access to electronic works over a network.

[wc_row][wc_column size=”one-fourth” position=”first”] [/wc_column][/wc_row] [wc_row][wc_column size=”one-fourth” position=”first”] [/wc_column][wc_column size=”three-fourth” position=”last”]

Chrysa Mineo 
Former SVP of Corporate Development, Receptos

Chrysa Mineo has over 26 years of experience in biotechnology, serving most recently on the executive team of Receptos as Senior Vice President, Corporate Development. Ms. Mineo joined Receptos in 2009 prior to the Series A funding round, and she led business development efforts to secure partnership for Receptos’ Phase 3 immunology/GI candidate ozanimod, which efforts ultimately resulted in the acquisition of Receptos by Celgene for $7.8 billion in July 2015. During her tenure at Receptos and through collaborations with AbbVie, Ono, Lilly and Janssen Pharmaceuticals, Ms. Mineo in-licensed a P2-ready clinical candidate and raised significant non-dilutive capital for Receptos. She also played a key role in the 2013 Receptos Initial Public Offering (IPO), leading the S-1 registration filing. Receptos ultimately raised over $700M in equity capital markets to advance multiple drug development programs in neuro-immunology and GI indications.

Prior to Receptos, Ms. Mineo spent 12 years with San Diego-based Neurocrine Biosciences in roles of increasing business development responsibility for neuroscience and metabolic-oriented drug development programs. Prior to Neurocrine, Ms. Mineo served in various capacities in research, marketing and business development for such companies as Amgen, DNAX Research Institute, Schering Plough and Baxter Biotech. She began her career in 1987 with Amgen as a member of a cellular biology team identifying a therapeutic role for Neupogen®. Ms. Mineo holds a B.S. in Zoology from the University of California, Davis and received her M.B.A. from Duke University’s Fuqua School of Business.

[/wc_column][wc_column size=”three-fourth” position=”last”]